Target intelligence / Profile preview

Central nervous system pathways involved in muscle spasm

Molecular classification
Other (neural circuit, not a single molecule), Neural pathway, Central nervous system circuit
01

Overview

The "central nervous system pathways involved in muscle spasm" refer to interconnected neural tracts in the brain and spinal cord, primarily including the corticospinal tract and extrapyramidal systems, which regulate motor neuron excitability, muscle tone, and reflexes. Dysfunction or hyperexcitability in these pathways, due to neurological disease or injury, leads to disordered muscle contractions, increased reflex activity, and clinically manifests as spasticity and muscle spasms. These pathways are complex and include both descending motor control and local spinal circuitry; they are not a single molecular entity but a physiological system composed of multiple neurons, synaptic connections, and neurotransmitter systems, making them unsuitable as a conventional drug target.

Other names
Descending motor pathwaysCorticospinal tractExtrapyramidal pathways (e.g., rubrospinal, reticulospinal, vestibulospinal, tectospinal tracts)Spinal motor circuitsSpasticity pathways
02

Mechanism of action

GABA receptor agonism (baclofen, diazepam); Alpha-2 adrenergic receptor agonism (tizanidine); Direct muscle relaxation via ryanodine receptor inhibition (dantrolene); Inhibition of acetylcholine release at neuromuscular junction (botulinum toxin); Unknown/complex: quinine (alters muscle excitability)

03

Biological functions

Regulation of muscle toneControl of voluntary and involuntary muscle contractionCoordination of movementMediation of stretch reflexesRegulation of spasticity and muscle spasms
04

Disease associations

Neurodegenerative disease (e.g., multiple sclerosis, motor neuron disease)Spasticity disordersOther neurological disorders involving motor dysfunction
05

Safety considerations

SedationMuscle weaknessRisk of dependency (benzodiazepines)Hepatotoxicity (tizanidine, dantrolene)Cardiac risks (quinine: QT prolongation, thrombocytopenia)
06

Interacting drugs

Baclofen

5 more in the full profile.

07

Biomarkers

There are no known molecular biomarkers specific to these neural pathways used for patient selection or efficacy monitoring in this context.

Beyond the preview

Go deeper on Central nervous system pathways involved in muscle spasm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Central nervous system pathways involved in muscle spasm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call